Showing posts with label
Sickle Cell Anemia
.
Show all posts
Showing posts with label
Sickle Cell Anemia
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Tuesday, July 15, 2025
An updated report (as of July 15 2025) on Beam Therapeutics (NASDAQ: BEAM):
›
🔬 1. Technology Advances & Pipeline Base editing leadership : Beam continues refining its precision base editing platform, enabl...
›
Home
View web version